Potential drug-drug interactions and polypharmacy in institutionalized elderly patients in a public hospital in Brazil

被引:16
|
作者
Castilho, E. C. D. [1 ]
Reis, A. M. M. [2 ]
Borges, T. L. [1 ]
Siqueira, L. D. C. [3 ]
Miasso, A. I. [1 ]
机构
[1] Univ Sao Paulo, Ribeirao Preto Nursing Sch, Psychiat Nursing & Human Sci Dept, Ribeirao Preto, SP, Brazil
[2] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil
[3] Grande Dourados Univ Hosp, Dourados, MS, Brazil
关键词
aged; drug interactions; drug therapy; health of the elderly; patient safety; polypharmacy; MEDICATION RECONCILIATION; PSYCHIATRIC-PATIENTS; INAPPROPRIATE MEDICATIONS; PSYCHOTROPIC MEDICATIONS; COHORT; PREVALENCE; FLUOXETINE; ADMISSIONS; MANAGEMENT; PAROXETINE;
D O I
10.1111/jpm.12431
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Accessible Summary What is known on the subject? Older individuals constitute an increasing proportion of the population, and therefore, are the major consumers of drugs. The elderly, especially those with mental disabilities, frequently develop chronic diseases and start using numerous drugs. Drug-drug interactions (DDIs) are a major clinical problem in the elderly population, and previous studies have focused only on antidepressants and others types of drugs used to treat mental health conditions. What this article adds to existing knowledge? This study shows that in hospitalized elderly patients with mental disorders (aged 60-69years), polypharmacy (5 drugs) and the use of drugs that act on the cardiovascular, respiratory and nervous systems can lead to potential drug-drug interactions. Moreover, it was reported that the prevalence of drug-drug interactions in elderly patients with mental disorders was high during their hospitalization in a public hospital in Brazil. What are the implications for practice? Nurses should know the factors associated with drug-drug interactions in hospitalized elderly patients with mental disorders to choose appropriate strategies for avoiding treatment failure and adverse events in patients. Abstract Introduction Despite the impact on patient safety and the fact that prevalence is higher in older patients, previous research did not analyse drug-drug interactions (DDIs) in view of nursing care of elderly psychiatric patients. Aim To identify potential drug-drug interactions and polypharmacy in prescriptions of aged inpatients with psychiatric disorders and analyse associated factors. Methods In this retrospective cross-sectional study, we analysed the medical records of institutionalized patients diagnosed with psychiatric disorders (n=94), aged >60years, and prescribed multiple medications. Drug prescriptions were checked at admission, midway through and the last prescription. Factors associated with DDI occurrence were assessed using multivariable logistic regression analysis. Results A DDI prevalence potential of 67.0%, 74.5% and 80.8% occurred in patients at admission, midway through hospitalization and the last prescription, respectively. Most of the prescribed drugs were nervous system agents. A high percentage of serious and contraindicated potential DDIs occurred. Age between 60 and 69years, use of cardiovascular and respiratory system drugs, and the number of medications contributed significantly to DDI. Implications for mental health nursing Knowledge on the factors associated with DDIs in patients with mental disorders can contribute to the improvement of effectiveness and safety of nursing care.
引用
收藏
页码:3 / 13
页数:11
相关论文
共 50 条
  • [21] Trends in polypharmacy and potential drug-drug interactions across educational groups in elderly patients in Sweden for the period 1992-2002
    Haider, S. I.
    Johnell, K.
    Thorslund, M.
    Fastbom, J.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2007, 45 (12) : 643 - 653
  • [22] Prevalence of polypharmacy and risk of potential drug-drug interactions among hospitalized patients with emphasis on the pharmacokinetics
    Georgiev, Kaloyan D.
    Hvarchanova, Nadezhda
    Stoychev, Elitsa
    Kanazirev, Branimir
    SCIENCE PROGRESS, 2022, 105 (01)
  • [23] Assessment of potential drug-drug interactions at hospital discharge
    Bertoli, R.
    Bissig, M.
    Caronzolo, D.
    Odorico, M.
    Pons, M.
    Bernasconi, E.
    SWISS MEDICAL WEEKLY, 2010, 140
  • [24] POLYPHARMACY AND POTENTIAL DRUG-DRUG INTERACTIONS IN OLDER CARDIOVASCULAR PATIENTS ACCORDING TO MEDICAL INFORMATION SYSTEM
    Anfinogenova, Nina
    Novikova, Oksana
    Efimova, Elena
    Maksimova, Aleksandra
    Shelkovnikova, Tatiana
    Ryumshina, Nadezhda
    Chesalov, Nazary
    Trubacheva, Irina
    Stepanov, Vadim
    Popov, Sergey
    Repin, Alexey
    ATHEROSCLEROSIS, 2024, 395
  • [25] Investigation of polypharmacy, antimicrobial-related potential drug-drug interactions in patients with hematological malignancies
    Oktay, Zeynep
    Guner, Rahmet
    Kayaaslan, Bircan
    Hasanoglu, Imran
    Kalem, Ayse Kaya
    Ozet, Gulsum
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2024,
  • [26] Drug-drug interactions in the elderly
    Björkman, IK
    Fastbom, J
    Schmidt, IK
    Bernsten, CB
    ANNALS OF PHARMACOTHERAPY, 2002, 36 (11) : 1675 - 1681
  • [27] Potential drug-drug interactions with direct oral anticoagulants in elderly hospitalized patients
    Forbes, Heather L.
    Polasek, Thomas M.
    THERAPEUTIC ADVANCES IN DRUG SAFETY, 2017, 8 (10) : 319 - 328
  • [28] Guidelines, polypharmacy, and drug-drug interactions in patients with multimorbidity A cascade of failure
    Marengoni, Alessandra
    Onder, Graziano
    BMJ-BRITISH MEDICAL JOURNAL, 2015, 350
  • [29] Rationale, design, and methodology of the EPIC (Epidemiology of Polypharmacy and Potential Drug-Drug Interactions in Elderly Cardiac Outpatients) study
    Ozlek, Eda
    Cekic, Edip Guvenc
    Ozlek, Bulent
    Cil, Cem
    Celik, Oguzhan
    Dogan, Volkan
    Basaran, Ozcan
    Tanik, Veysel Ozan
    Ozdemir, Halil Ibrahim
    Celik, Yunus
    Kacmaz, Caner
    Simsek, Zeki
    Gunes, Haci Murat
    Safak, Ozgen
    Ozkan, Bugra
    Tasar, Onur
    Onal, Cagatay
    Bekar, Lutfu
    Biteker, Murat
    TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, 2019, 47 (05): : 391 - 398
  • [30] Potential drug-drug interactions in outpatient lung cancer patients in a university hospital
    Demirkapu, Mahluga Jafarova
    Cavdar, Eyyup
    PHARMACOLOGY, 2024, 109 (04) : 231 - 236